Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats

被引:11
作者
Bach, Harold H. [1 ,2 ]
LaPorte, Heather M. [1 ]
Wong, Yee M. [1 ]
Gamelli, Richard L. [1 ]
Majetschak, Matthias [1 ,2 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA
[2] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA
关键词
Bortezomib; resuscitation; ATP; 26S proteasome; male Lewis rats; ISCHEMIA-REPERFUSION INJURY; HUMAN SKELETAL-MUSCLE; VENTRICULAR TACHYARRHYTHMIAS; MYOCARDIAL-INFARCTION; 20S PROTEASOME; LUNG INJURY; MODEL; SPECTROSCOPY; BORTEZOMIB; SYSTEM;
D O I
10.1097/TA.0b013e31827d5db2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Several lines of evidence suggest that proteasomes, the major nonlysosomal proteases in eukaryotes, are involved in the pathophysiology of various disease processes, including ischemia-reperfusion injury and trauma. Recently, we demonstrated that 26S proteasome activity is negatively regulated by adenosine triphosphate (ATP) and that proteasome activation during ischemia contributes to myocardial injury. The regulation of tissue proteasome activity by ATP and the potential of proteasomes as drug targets during hemorrhagic shock, however, are unknown. Thus, we evaluated the regulation of tissue proteasome peptidase activity and the effects of the proteasome inhibitor bortezomib in rat models of hemorrhagic shock. METHODS: Series 1 includes animals (n = 20) hemorrhaged to a mean arterial blood pressure of 30 mm Hg for up to 45 minutes. Series 2 includes animals hemorrhaged to a mean arterial blood pressure of 30 mm Hg for 30 minutes, followed by bortezomib (0.4 mg/kg) or vehicle administration (n = 5 per group) and fluid resuscitation until 75 minutes. Series 3 includes animals that underwent 40% blood volume hemorrhage, followed by 2% blood volume hemorrhage every 15 minutes until death. Bortezomib (0.4 mg/kg) or vehicle were administered 15 minutes after the onset of hemorrhage (n = 6-7 per group). Vital signs were continuously monitored. The heart, lung, and pectoral muscle were analyzed for proteasome peptidase activities and levels of ATP, ubiquitin-protein conjugates, and cytokines (tumor necrosis factor alpha, interleukin 6, and interleukin 10). RESULTS: In Series 1, proteasome peptidase activities in tissue extracts increased proportional to the decrease in tissue ATP concentrations during hemorrhagic shock. Activation of proteasome peptidase activity with decreases of the ATP assay concentration was also detectable in normal tissue extracts. In Series 2, systemic administration of bortezomib inhibited tissue proteasome activities but did not affect the physiologic response. In Series 3, bortezomib inhibited tissue proteasome activities, increased endogenous ubiquitin-protein conjugates, and prolonged survival time from treatment from 48.5 minutes in the control group to 85 minutes (p = 0.0012). Bortezomib treatment did not affect tissue cytokine levels. CONCLUSION: Proteasome activation contributes to the pathophysiology of severe hemorrhagic shock. Pharmacologic inhibition of the proteasome may provide a survival advantage during lethal hemorrhagic shock. (J Trauma Acute Care Surg. 2013; 74: 499-507. Copyright (C) 2013 by Lippincott Williams & Wilkins)
引用
收藏
页码:499 / 507
页数:9
相关论文
共 43 条
[31]   Advances in and applications of proteasome inhibitors [J].
Moore, Bradley S. ;
Eustaquio, Alessandra S. ;
McGlinchey, Ryan P. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (04) :434-440
[32]   Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib [J].
Nowis, Dominika ;
Maczewski, Michal ;
Mackiewicz, Urszula ;
Kujawa, Marek ;
Ratajska, Anna ;
Wieckowski, Mariusz R. ;
Wilczynski, Grzegorz M. ;
Malinowska, Monika ;
Bil, Jacek ;
Salwa, Pawel ;
Bugajski, Marek ;
Wojcik, Cezary ;
Sinski, Maciej ;
Abramczyk, Piotr ;
Winiarska, Magdalena ;
Dabrowska-Iwanicka, Anna ;
Duszyniski, Jerzy ;
Jakobisiak, Marek ;
Golab, Jakub .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (06) :2658-2668
[33]   Ubiquitin-independent proteolytic functions of the proteasome [J].
Orlowski, M ;
Wilk, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 415 (01) :1-5
[34]   THE MULTICATALYTIC PROTEINASE COMPLEX, A MAJOR EXTRALYSOSOMAL PROTEOLYTIC SYSTEM [J].
ORLOWSKI, M .
BIOCHEMISTRY, 1990, 29 (45) :10289-10297
[35]   Dynamics of tissue ubiquitin pools and ubiquitin-proteasome pathway component activities during the systemic response to traumatic shock [J].
Patel, M. B. ;
Earle, S. A. ;
Majetschak, M. .
PHYSIOLOGICAL RESEARCH, 2007, 56 (05) :547-557
[36]   The Treatment of Traumatic Brain Injury with Velcade [J].
Qu, Changsheng ;
Mahmood, Asim ;
Ning, Ruizhuo ;
Xiong, Ye ;
Zhang, Li ;
Chen, Jieli ;
Jiang, Hao ;
Chopp, Michael .
JOURNAL OF NEUROTRAUMA, 2010, 27 (09) :1625-1634
[37]   Regulation of the ubiquitin proteasome system in mechanically injured human skeletal muscle [J].
Seiffert, M. ;
Gosenca, D. ;
Ponelies, N. ;
Ising, N. ;
Patel, M. B. ;
Obertacke, U. ;
Majetschak, M. .
PHYSIOLOGICAL RESEARCH, 2007, 56 (02) :227-233
[38]   Proteasomal inhibition in intracerebral hemorrhage: Neuroprotective and anti-inflammatory effects of bortezomib [J].
Sinn, Dong-In ;
Lee, Soon-Tae ;
Chu, Kon ;
Jung, Keun-Hwa ;
Kim, Eun-Hee ;
Kim, Jeong-Min ;
Park, Dong-Kyu ;
Song, Eun-Cheol ;
Kim, Byung-Su ;
Yoon, Sung-Soo ;
Kim, Manho ;
Roh, Jae-Kyu .
NEUROSCIENCE RESEARCH, 2007, 58 (01) :12-18
[39]   Proteasome inhibition attenuates lung injury induced by intestinal ischemia reperfusion in rats [J].
Tian, Xiao-Feng ;
Zhang, Xue-Song ;
Li, Ying-Hua ;
Wang, Zheng-zheng ;
Zhang, Feng ;
Wang, Li-Ming ;
Yao, Ji-Hong .
LIFE SCIENCES, 2006, 79 (22) :2069-2076
[40]   Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle [J].
Tiao, G ;
Hobler, S ;
Wang, JJ ;
Meyer, TA ;
Luchette, FA ;
Fischer, JE ;
Hasselgren, PO .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :163-168